Hyperglycaemia induces endothelial dysfunction via epigenetic regulation driven by histone methyltransferase EZH2

被引：0
|
作者：
Sanchez-Ceinos, J. [1 ]
Hussain, S. [1 ]
Waheed-Khan, A. [1 ,2 ]
Zhang, L. [1 ]
Pernow, J. [1 ]
Cosentino, F. [1 ]
机构：
[1] Karolinska Inst, Karolinska Univ Hosp, Cardiol Unit, Med, Stockholm, Sweden
[2] Monash Univ, Cent Clin Sch, Diabet, Melbourne, Vic, Australia
来源：
DIABETOLOGIA | 2022年 / 65卷 / SUPPL 1期
基金：
瑞典研究理事会;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
268
引用
收藏
页码：S142 / S142
页数：1
相关论文
共 50 条
  • [31] Histone Methyltransferase EZH2: A Therapeutic Target for Ovarian Cancer
    Jones, Bayley A.
    Varambally, Sooryanarayana
    Arend, Rebecca C.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (03) : 591 - 602
  • [32] Role of the EZH2 histone methyltransferase as a therapeutic target in cancer
    Italiano, Antoine
    PHARMACOLOGY & THERAPEUTICS, 2016, 165 : 26 - 31
  • [33] The Role of the Histone Methyltransferase EZH2 in the Mouse Intestinal Epithelium
    Aoki, Reina
    Kaestner, Klaus H.
    GASTROENTEROLOGY, 2014, 146 (05) : S519 - S519
  • [34] Biological evaluation of tanshindiols as EZH2 histone methyltransferase inhibitors
    Woo, Jimin
    Kim, Hyun-Young
    Byun, Byung Jin
    Chae, Chong-Hak
    Lee, Ji Young
    Ryu, Shi Yong
    Park, Woo-Kyu
    Cho, Heeyeong
    Choi, Gildon
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (11) : 2486 - 2492
  • [35] Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2
    Mandal, Malay
    Powers, Sarah E.
    Maienschein-Cline, Mark
    Bartom, Elizabeth T.
    Hamel, Keith M.
    Kee, Barbara L.
    Dinner, Aaron R.
    Clark, Marcus R.
    NATURE IMMUNOLOGY, 2011, 12 (12) : 1212 - U107
  • [36] Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2
    Malay Mandal
    Sarah E Powers
    Mark Maienschein-Cline
    Elizabeth T Bartom
    Keith M Hamel
    Barbara L Kee
    Aaron R Dinner
    Marcus R Clark
    Nature Immunology, 2011, 12 : 1212 - 1220
  • [37] Implication of the histone methyltransferase EZH2 in pulmonary arterial hypertension
    Habbout, Karima
    Provencher, Steeve
    Bonnet, Sebastien
    Boucherat, Olivier
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [38] Inactivating mutations of the histone methyltransferase EZH2 in myeloid disorders
    Ernst, T.
    Chase, A.
    Score, J.
    Hidalgo-Curtis, C.
    Bryant, C.
    Jones, A.
    Waghorn, K.
    Zoi, K.
    Ross, F.
    Reiter, A.
    Hochhaus, A.
    Drexler, H.
    Duncombe, A.
    Cervantes, F.
    Oscier, D.
    Boultwood, J.
    Grand, F.
    Cross, N.
    ONKOLOGIE, 2010, 33 : 118 - 118
  • [39] The histone methyltransferase Ezh2 restrains macrophage inflammatory responses
    Kitchen, Gareth B.
    Hopwood, Thomas
    Ramamoorthy, Thanuja Gali
    Downton, Polly
    Begley, Nicola
    Hussell, Tracy
    Dockrell, David H.
    Gibbs, Julie E.
    Ray, David W.
    Loudon, Andrew S., I
    FASEB JOURNAL, 2021, 35 (10):
  • [40] Blockade of endothelial to mesenchymal transition (EndMT) by an inhibitor of histone methyltransferase EZH2 attenuates atherosclerosis in diabetes
    Khan, A. W.
    Aziz, M.
    Sourris, K.
    Okabe, J.
    Jandeleit-Dahm, K. A. M.
    EUROPEAN HEART JOURNAL, 2024, 45
12345